Moderna MRNA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$1.34B-38.3% | -$826M+26.3% | -$200M-1,638% | -$825M+35.5% | -$971M+17.4% | ||
| $59M+51.3% | $67M+11.7% | $52M0.0% | $57M+39.0% | $39M+8.3% | ||
| $104M-9.6% | $113M+8.7% | $125M+11.6% | $130M+16.1% | $115M+13.9% | ||
| -$630M+39.2% | —— | -$847M+45.9% | -$919M+27.9% | -$1.04B-4.9% | ||
| $62M-47.0% | $39M-92.5% | $33M-78.1% | $3M-98.4% | $117M-40.3% | ||
| -$76M-110% | $0— | $700M-2.9% | $564M-65.8% | $730M+519% | ||
| —— | $150M— | $150M— | $150M— | $150M— | ||
| $17M+325% | $581M— | $0-100% | $9M-73.5% | $4M-71.4% | ||
| -$688M-127% | $1.46B— | -$147M+82.4% | -$345M— | -$303M+64.6% | ||
| -$692M+40.0% | —— | -$880M+48.7% | -$922M+36.7% | -$1.15B+2.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Moderna generate?
- Moderna (MRNA) generated -$3.4B in operating cash flow over the trailing twelve months.
- What is Moderna's free cash flow?
- After $137.0M of capital expenditures, Moderna's free cash flow was -$3.6B over the trailing twelve months, up 16.3% year over year.
- Where does Moderna's cash flow data come from?
- Every line is extracted from Moderna's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
